Patent details
EP2046349
Title:
TREATMENT OF EXCESSIVE NEOVASCULARIZATION
Basic Information
- Publication number:
- EP2046349
- PCT Application Number:
- PCT/AU/2007/000974
- Type:
- European Patent Granted for LU
- Legal Status:
- Lapsed
- Application number:
- EP077846418
- PCT Publication Number:
- WO/2008/006168
- First applicant's nationality:
- Translation Language:
- EPO Publication Language:
- English
- English Title of Invention:
- TREATMENT OF EXCESSIVE NEOVASCULARIZATION
- French Title of Invention:
- TRAITEMENT DE LA NÉOVASCULARISATION EXCESSIVE
- German Title of Invention:
- BEHANDLUNG VON EXZESSIVER NEOVASKULARISATION
- SPC Number:
-
Dates
- Filing date:
- 12/07/2007
- Grant date:
- 09/09/2015
- EP Publication Date:
- 09/09/2015
- PCT Publication Date:
- 17/01/2008
- Claims Translation Received Date:
- Translations Received Date (B1 EP Publication):
- Translations Received Date (B2 EP Publication):
- Translations Received Date (B3 EP Publication):
- Publication date:
- 15/04/2009
- EP B1 Publication Date:
- 09/09/2015
- EP B2 Publication Date:
- EP B3 Publication Date:
- Lapsed date:
- 12/07/2016
- Expiration date:
- 12/07/2027
- Renunciation date:
- Revocation date:
- Annulment date:
Owner
- From:
- 30/01/2016
-
-
- Name:
- Mesoblast Inc.
- Address:
- 505 Fifth Avenue, Third Floor, New York, NY 10017, United States (US)
Inventor
- Name:
- RAKOCZY Piroska, Elizabeth
- Address:
- Australia (AU)
Priority
1
- Priority Number:
- 830651 P
- Priority Date:
- 12/07/2006
- Priority Country:
- United States (US)
2
- Priority Number:
- 830649 P
- Priority Date:
- 12/07/2006
- Priority Country:
- United States (US)
Classification
- Main IPC Class:
-
A61K 35/28;
Annual Fees
- Annual Fee Due Date:
-
- Annual Fee Number:
-
- Expected Payer:
-
- Last Annual Fee Payment Date:
-
- Last Annual Fee Paid Number:
-
- Payer:
-
Filing date |
Document type |
Number of pages |